Features of brain MRI in dogs with treated and untreated mucopolysaccharidosis type i

Comparative Medicine

Volumn 63, Issue 2, 2013, Pages 163-173

  Vite, Charles H ^a   Nestrasil, Igor ^b   Mlikotic, Anton ^c   Jens, Jackie K ^d   Snella, Elizabeth M ^d   Gross, William ^d   Shapiro, Elsa G ^b   Kovac, Victor ^b   Provenzale, James M ^e,f   Chen, Steven ^e   Le, Steven Q ^c   Kan, Shih Hsin ^c   Banakar, Shida ^c   Wang, Raymond Y ^g   Haskins, Mark E ^a   Ellinwood, N Matthew ^d   Dickson, Patricia I ^c  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d IOWA STATE UNIVERSITY   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; BETA N ACETYLHEXOSAMINIDASE; LEVO IDURONIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BRAIN CORTEX ATROPHY; BRAIN SIZE; BRAIN VENTRICLE DILATATION; BRAIN WEIGHT; CISTERNA MAGNA; COMMUNICATING HYDROCEPHALUS; CONTROLLED STUDY; CORPUS CALLOSUM; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME REPLACEMENT; FEMALE; HETEROZYGOTE; HURLER SYNDROME; JUVENILE ANIMAL; MALE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PULSE OXIMETRY; TREATMENT DURATION; WHITE MATTER LESION; WHOLE BODY MRI;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DOGS; ENZYME REPLACEMENT THERAPY; FEMALE; IDURONIDASE; MAGNETIC RESONANCE IMAGING; MALE; MUCOPOLYSACCHARIDOSIS I; NEUROIMAGING; RECOMBINANT PROTEINS;

EID: 84877849775     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ballesteros MC, Hansen PE, Soila K. 1993. MR imaging of the developing human brain. Part 2. Postnatal development. Radiographics 13:611-622.
2. Carlstrom LP, Jens JK, Dobyns ME, Passage MB, Dickson PI, Ellinwood NM. 2009. Inadvertent propagation of factor VII deficiency in a canine mucopolysaccharidosis type I research breeding colony. Comp Med 59:378-382.
3. Chen A, Vogler C, Levy B, McEntee MF, Passage M, Le S, Guerra C, Dickson P. 2011. Glycosaminoglycan storage in neuroanatomical regions of mucopolysaccharidosis I dogs following intrathecal recombinant human iduronidase. APMIS 119:513-521.
4. De Haan CE, Kraft SL, Gavin PR, Wendling LR, Griebenow ML. 1994. Normal variation in size of the lateral ventricles of the Labrador retriever dog as assessed by magnetic resonance imaging. Vet Radiol Ultrasound 35:83-86.
5. Dickson P, McEntee M, Vogler C, Le S, Levy B, Peinovich M, Hanson S, Passage M, Kakkis E. 2007. Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid. Mol Genet Metab 91:61-68. (Pubitemid 46550919)
6. Dickson PI, Ellinwood NM, Brown JR, Witt RG, Le SQ, Passage MB, Vera MU, Crawford BE. 2012. Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I. Mol Genet Metab 106:68-72.
7. Dickson PI, Hanson S, McEntee MF, Vite CH, Vogler CA, Mlikotic A, Chen AH, Ponder KP, Haskins ME, Tippin BL, Le SQ, Passage MB, Guerra C, Dierenfeld A, Jens J, Snella E, Kan Sh, Ellinwood NM. 2010. Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I. Mol Genet Metab 101:115-122.
8. Dierenfeld AD, McEntee MF, Vogler CA, Vite CH, Chen AH, Passage M, Le S, Shah S, Jens JK, Snella EM, Kline KL, Parkes JD, Ware WA, Moran LE, Fales-Williams AJ, Wengert JA, Whitley RD, Betts DM, Boal AM, Riedesel EA, Gross W, Ellinwood NM, Dickson PI. 2010. Replacing the enzyme α-l-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I. Sci Transl Med 2:60ra89.
9. Dramsdahl M, Westerhausen R, Haavik J, Hugdahl K, Plessen KJ. 2012. Adults with attention-deficit-hyperactivity disorder: a diffusion-tensor imaging study of the corpus callosum. Psychiatry Res 201:168-173.
10. Ellinwood NM, Colle MA, Weil MA, Casal ML, Vite CH, Wiemelt S, Hasson CW, O'Malley TM, He X, Prociuk U, Verot L, Melniczek JR, Lannon A, Aguirre GD, Knox VW, Evans SM, Vanier MT, Schuchman EH, Walkley SU, Haskins ME. 2007. Bone marrow transplantation for feline mucopolysaccharidosis I. Mol Genet Metab 91:239-250. (Pubitemid 46819119)
11. Ellinwood NM, Vite CH, Haskins ME. 2004. Gene therapy for lysosomal storage diseases: the lessons and promise of animal models. J Gene Med 6:481-506. (Pubitemid 40228065)
12. Fan Z, Styner M, Muenzer J, Poe M, Escolar M. 2010. Correlation of automated volumetric analysis of brain MR imaging with cognitive impairment in a natural history study of mucopolysaccharidosis II. AJNR Am J Neuroradiol 31:1319-1323.
13. Fowler GW, Sukoff M, Hamilton A, Williams JP. 1975. Communicating hydrocephalus in children with genetic inborn errors of metabolism. Childs Brain 1:251-254.
14. Gabrielli O, Polonara G, Regnicolo L, Petroni V, Scarabino T, Coppa GV, Salvolini U. 2004. Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses. Am J Med Genet A 125A:224-231. (Pubitemid 38294839)
15. Gross B, Garcia-Tapia D, Riedesel E, Ellinwood NM, Jens JK. 2010. Normal canine brain maturation at magnetic resonance imaging. Vet Radiol Ultrasound 51:361-373.
16. Hartung SD, Frandsen JL, Pan D, Koniar BL, Graupman P, Gunther R, Low WC, Whitley CB, McIvor RS. 2004. Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human α-l-iduronidase gene. Mol Ther 9:866-875. (Pubitemid 38878132)
17. Lee C, Dineen TE, Brack M, Kirsch JE, Runge VM. 1993. The mucopolysaccharidoses: characterization by cranial MR imaging. AJNR Am J Neuroradiol 14:1285-1292. (Pubitemid 23334619)
18. Lücke T, Das AM, Hartmann H, Sykora K-W, Donnerstag F, Schmid-Ott G, Grigull L. 2007. Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study. Dev Med Child Neurol 49:693-696. (Pubitemid 47316792)
19. MacBrinn M, Okada S, Woollacott M, Patel V, Ho MW, Tappel AL, O'Brien JS. 1969. β-galactosidase deficiency in the Hurler syndrome. N Engl J Med 281:338-343.
20. Magnotta VA, Harris G, Andreasen NC, O'Leary DS, Yuh WT, Heckel D. 2002. Structural MR image processing using the BRAINS2 toolbox. Comput Med Imaging Graph 26:251-264. (Pubitemid 34628869)
21. Matheus MG, Castillo M, Smith JK, Armao D, Towle D, Muenzer J. 2004. Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 46:666-672. (Pubitemid 39199525)
22. Minami R, Nakamura FF, Kudoh TF, Oyanagi KF, Nakao T. 1980. An altered hexosaminidase A in the liver affected by Hurler and Hunter syndromes. Tohoku J Exp Med 132:329-335. (Pubitemid 11182502)
23. Nagel BJ, Bathula D, Herting M, Schmitt C, Kroenke CD, Fair D, Nigg JT. 2011. Altered white matter microstructure in children with attention-deficit- hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 50:283-292.
24. Provenzale JM, Liang L, DeLong D, White LE. 2007. Diffusion tensor imaging assessment of brain white matter maturation during the first postnatal year. AJR Am J Roentgenol 189:476-486. (Pubitemid 47195935)
25. Seto T, Kono K, Morimoto K, Inoue Y, Shintaku H, Hattori H, Matsuoka O, Yamano T, Tanaka A. 2001. Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann Neurol 50:79-92.
26. Shapiro E, Guler OE, Rudser K, Delaney K, Bjoraker K, Whitley C, Tolar J, Orchard P, Provenzale J, Thomas K. 2012. An exploratory study of brain function and structure in mucopolysaccharidosis type I: long-term observations following hematopoietic cell transplantation (HCT). Mol Genet Metab 107:116-121.
27. Shull RM, Munger RJ, Spellacy E, Hall CW, Constantopoulos G, Neufeld EF. 1982. Canine α-L-iduronidase deficiency. A model of mucopolysaccharidosis I. Am J Pathol 109:244-248. (Pubitemid 13234158)
28. Vedolin L, Schwartz IVD, Komlos M, Schuch A, Puga AC, Pinto LLC, Pires AP, Giugliani R. 2007. Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II. AJNR Am J Neuroradiol 28:1029-1033. (Pubitemid 46984534)
29. Visigalli I, Delai S, Politi LS, Di Domenico C, Cerri F, Mrak E, D'Isa R, Ungaro D, Stok M, Sanvito F, Mariani E, Staszewsky L, Godi C, Russo I, Cecere F, del Carro U, Rubinacci A, Brambilla R, Quattrini A, Di Natale P, Ponder K, Naldini L, Biffi A. 2010. Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model. Blood 116:5130-5139.
30. Vite CH, Insko EK, Schotland HM, Panckeri K, Hendricks JC. 1997. Quantification of cerebral ventricular volume in English bulldogs. Vet Radiol Ultrasound 38:437-443. (Pubitemid 127460782)
31. Vite CH, Wang P, Patel RT, Walton RM, Walkley SU, Sellers RS, Ellinwood NM, Cheng AS, White JT, O'Neill CA, Haskins M. 2011. Biodistribution and pharmacodynamics of recombinant human α-liduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations. Mol Genet Metab 103:268-274.
32. Wang D, Zhang W, Kalfa TA, Grabowski G, Davies S, Malik P, Pan D. 2009. Reprogramming erythroid cells for lysosomal enzyme production leads to visceral and CNS cross-correction in mice with Hurler syndrome. Proc Natl Acad Sci USA 106:19958-19963.
33. Wood SL, Beyer BK, Cappon GD. 2003. Species comparison of postnatal CNS development: functional measures. Birth Defects Res B Dev Reprod Toxicol 68:391-407. (Pubitemid 38222015)
34. Yakovlev PI, Lecours AR. 1967. The myelogenetic cycles of regional maturation of the brain, p 3-70. In: Minkowski A, editor. Regional development of the brain in early life. Oxford (UK): Blackwell Scientific.